Guidance

Hexavalent combination vaccine: programme guidance

Guidance for healthcare professionalspractitioners on the hexavalent vaccine programmeprogramme, forincluding babiesits bornuse afterin the selective neonatal hepatitis B programme, from 1 AugustJuly 2017.2025.

Applies to England

Documents

Appendix A: the number of hepatitis-B containing vaccine doses for children flowchart

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

All babies born on or after 1 August 2017 are eligible for the hexavalent vaccine, which includes hepatitis B (HepB), for their primary immunisations.

In 2022,From July 2025, the UKroutine Healthchildhood Securityimmunisation Agencyschedule (UKHSA)changed, and children born on or after 1 July 2024 will supplyreceive Vaxelis®an inadditional additionhexavalent tovaccine Infanrixat hexa®18 months of age. The selective neonatal hepatitis B pathway for usechildren inborn theto primarywomen immunisationwith schedule.hepatitis B was also amended.

This documentguidance is aimed at healthcare practitioners involved in the programme and provides information about the 2 hexavalent vaccines for( healthcareVaxelis® practitionersand whoInfanrix arehexa®), involvedincluding ininformation deliveringon orthe advisingchanges, oneligibility, thescheduling infantand primaryvaccine vaccinationadministration. Separate programme.information Itfor hashealthcare beenpractitioner updatedguidance, tospecifically includecovering the changes to the routine childhood vaccinationschedule schedule.from 1 July 2025, is also available.

ForMore more information on the childhood changes to the vaccination schedule

Updates to this page

Published 5 July 2017
Last updated 292 MayJune 2025 + show all updates
  1. Updates made to the guidance for healthcare practitioners relating to the changes to the childhood schedule from 1 July 2025. Additional appendix A added.

  2. Added new slide set which includes all the changes to the childhood vaccination programme.

  3. Added updated guidance and training slide set.

  4. Updated information on incomplete or uncertain vaccination histories and stability of Vaxelis.

  5. Added updated information for healthcare practitioners and link to updated training slide set.

  6. Updated with revised infant PCV schedule and removed Hepatitis B pre-school booster recommendation.

  7. Routine programme guidance has been updated to include additional information about action to take when hexavalent vaccine is given when pentavalent should have been given.

  8. The routine and selective guidance documents have been revised to comply with accessibility guidelines.

  9. First published.

Sign up for emails or print this page